Role of spleen or spleen products in the reduced locomotor-enhancing effect of morphine in diabetic mice

Neuroscience Letters

Volumn 210, Issue 1, 1996, Pages 57-60

  Kamei, Junzo ^a   Saitoh, Akiyoshi ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Diabetes; Locomotor activity; Morphine; Spleen; Splenectomy; Opioid receptors

Indexed keywords

MORPHINE; MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLENECTOMY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029935999     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12662-8     Document Type: Article

References (15)

1. Borel, J.F., Feurer, C., Magnee, C. and Staehelin, H., Effects of new anti-lymphocytic peptide cyclosporine a in animals, Immunology, 32 (1976) 1017-1025.
2. Brase, D.A., Han, T.H. and Dewey, W.L., Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain, Diabetes, 36 (1987) 1173-1177.
3. Hirabayashi, M. and Alam, M.R., Enhancing effect of methamphetamine on ambulatory activity produced by repeated administration in mice, Pharmacol. Biochem. Behav., 15 (1981) 925-932.
4. Kamei, J., Kawashima, N. and Kasuya, Y., Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice, Brain Res., 576 (1992) 139-142.
5. Kamei, J., Kawashima, N., Suzuki, T., Misawa, M. and Kasuya, Y., The effects of cyclosporine on morphine-induced antinociception in diabetic mice, Neurosci. Lett., 158 (1993) 213-216.
6. 2-mediated mechanisms in μ-mediated antitussive activity in mouse, Neurosci. Lett., 149 (1993) 169-172.
7. 1-receptor deficient CXBK mouse, Eur. J. Pharmacol., 240 (1993) 99-101.
8. Kamei, J., Iwamoto, Y., Misawa, M., Nagase, H. and Kasuya, Y., Evidence for differential modulation of μ-opioid receptor-mediated antinociception and antitussive activities by spleen-derived factor(s) from diabetic mice, Neuropharmacology, 33 (1994) 1553-1558.
9. Kamei, J., Ohsawa, M., Saitoh, A., Iwamoto, Y., Suzuki, T., Misawa, M., Nagase, H. and Kasuya, Y., Modification of μ-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes, J. Pharmacol. Exp. Ther., 274 (1995) 700-706.
10. Kamei, J., Saitoh, A., Iwamoto, Y., Funada, M., Suzuki, T., Misawa, M., Nagase, H. and Kasuya, Y., Effects of diabetes on spontaneous locomotor activity in mice, Neurosci. Lett., 178 (1994) 69-72.
11. Kimball, E.S., Raffa, R.B. and Mathiasen, J.R., Obligatory role of B cells and adherent accessory cells in the transfer of a defect in morphine-mediated antinociception in C57BL/6J-bg/bg (beige-J) mice, J. Neuroimmunol., 22 (1989) 185-192.
12. Kristen, M., Brett, J., Radoff, S., Ogawa, S., Stern, D. and Vlassara, H., Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging, Proc. Natl. Acad. Sci. USA., 87 (1990) 9010-9014.
13. J (beige) mice: differential sensitivity in tail flick test to centrally administered mu-and delta-opioid receptor agonists, Life Sci., 40 (1987) 1989-1994.
14. J (beige; Chediak-Higashi syndrome) mice transmitted by adoptive transfer of spleen cells to normal litter-mates, Life Sci., 42 (1988) 1231-1236.
15. Raffa, R.B., Mathiasen, J.R., Kimball, E.S. and Vaught, J.L., The combined immunological and antinociceptive defects of beige mice: the possible existence of a 'μ-repression', Life Sci., 52 (1993) 1-8.